HEMOGLOBINOPATHY
Clinical trials for HEMOGLOBINOPATHY explained in plain language.
Never miss a new study
Get alerted when new HEMOGLOBINOPATHY trials appear
Sign up with your email to follow new studies for HEMOGLOBINOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy Follow-Up: 13-Year watch on sickle cell patients begins
Disease control Recruiting nowThis study follows 50 people with sickle cell disease who received the gene therapy BEAM-101 in an earlier trial. Researchers will monitor them for 13 years to check for long-term side effects, new health problems, and how well the treatment controls their disease. The goal is to…
Matched conditions: HEMOGLOBINOPATHY
Sponsor: Beam Therapeutics Inc. • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
How long do red blood cells live? new study aims to find out
Knowledge-focused Recruiting nowThis study measures how long red blood cells survive in people with sickle cell disease and other inherited blood disorders. Researchers will label participants' own red blood cells with biotin (a vitamin) and track them over time. The goal is to compare cell survival between peo…
Matched conditions: HEMOGLOBINOPATHY
Phase: EARLY_PHASE1 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated May 26, 2026 03:54 UTC